Abstract

Myocardial proteasomes are comprised of 20S core particles and 19S regulatory particles, which together carry out targeted degradation of cardiac proteins. The 19S complex is unique among the regulators of proteasomes in that it affects both the capacity and specificity of protein degradation. However, a comprehensive molecular characterization of cardiac 19S complexes is lacking. In this investigation, we tailored a multidimensional chromatography-based purification strategy to isolate structurally intact and functionally viable 19S complexes from murine hearts. Two distinct subpopulations of 19S complexes were isolated based upon (1) potency of activating 20S proteolytic activity, and (2) molecular composition using a combination of immuno-detection, two-dimensional-differential gel electrophoresis, and MS-based approaches. Heat shock protein 90 (Hsp90) was identified to be characteristic to 19S subpopulation I. The physical interaction of Hsp90 with 19S complexes was demonstrated via multiple approaches. Inhibition of Hsp90 activity using geldanamycin or BIIB021 potentiated the ability of subpopulation I to activate 20S proteasomes in the murine heart, thus demonstrating functional specificity of Hsp90 in subpopulation I. This investigation has advanced our understanding of the molecular heterogeneity of cardiac proteasomes by identifying molecularly and functionally distinct cardiac 19S complexes. The preferential association of Hsp90 with 19S subpopulation I unveils novel targets for designing proteasome-based therapeutic interventions for combating cardiac disease.

Highlights

  • The proteasome system governs protein turnover and regulates essential signaling cascades in cardiac biology [1, 2]

  • Heat shock protein 90 (Hsp90) was identified as a unique associating partner of 19S subpopulation I, which we further demonstrated to be a negative regulator of 19S I-induced activation of 20S

  • The molecular components of 19S I and 19S subpopulation II (19S II) were identified with an LC-MS/MSbased analysis after one dimensional SDS-PAGE separation

Read more

Summary

EXPERIMENTIAL PROCEDURES

All procedures were performed in accordance with the Animal Research Committee guidelines at the University of California, Los Angeles and the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health. Detailed procedures can be found in the supplemental materials (supplemental Fig. S2). Cytosolic fraction was collected by centrifugation and prefractionated with DE52 resin (GE Healthcare). The fraction recovered with 400 mM NaCl was further enriched with ammonium sulfate precipitation (30 – 40% saturation) and dialyzed overnight at 4 °C. Low molecular weight proteins were removed via Sephacryl S-400 gel-filtration (GE Healthcare). The 19S containing fractions were pooled and resolved with DEAE Sepharose Fast Flow chromatography (GE Healthcare).

The abbreviations used are
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call